Table 2.
Summary of the effect of prenatal vitamin D supplementation on respiratory health parameters (pooled RR)
| Outcome | Meta-analysis |
Heterogeneity |
||||
|---|---|---|---|---|---|---|
| RR | (95% CI) | P-value | I2 | P-value | ||
| 1 | Asthma | 0.89 | (0.69–1.15) | 0.37 | 46% | 0.10 |
| 2 | Eczema | 0.95 | (0.82–1.10) | 0.51 | 0% | 0.95 |
| 3 | LRTIs | 0.95 | (0.85–1.06) | 0.37 | 0% | 0.95 |
| 4 | IgEa | 0.34 | (0.12–1.00) | 0.05 | – | |
| IgEb | 1.03 | (0.79–1.33) | 0.85 | 60% | 0.06 | |
| IgE total | 0.97 | (0.73–1.29) | 0.82 | 63% | 0.03 | |
| 5 | URTIs | 0.89 | (0.73–1.07) | 0.22 | 0% | 0.58 |
| 6 | Allergic rhinitis | 1.03 | (0.69–1,54) | 0.87 | 43% | 0.17 |
IgE; Immunoglobulin E, LRTI; Lower respiratory tract infection, URTI; Upper respiratory tract infection, RR; relative risk.
Subgroup analysis of children who received vitamin D in the first 6 months.
children who didn't receive vitamin D supplementation.